Home/Hedge Fund Intelligence/Avalo Therapeutics, Inc.
Nasdaq: AVTXStockForm 13F30 Jun 2026

Hedge funds that hold Avalo Therapeutics, Inc. New Nasdaq: AVTX

New · CUSIP 05338F306 · who reports it, how much, and how much it matters to them

31 of the 720 hedge fund managers we track reported shares of Avalo Therapeutics, Inc. (Nasdaq: AVTX) on Form 13F for 30 June 2026. Between them they reported USD 409m. The largest position belongs to Deep Track Capital, at USD 67m. The manager with the most riding on it is Ally Bridge Group (Ny), where it is 2.5% of the reported book.

Managers reporting it31of 720 we track
Value they reportUSD 409mshares only, 30 Jun 2026
Funds they run317with a file on PPLI.com
Largest positionUSD 67mDeep Track Capital
Typical weight0.1%median share of a manager's book
Heaviest weight2.5%Ally Bridge Group (Ny)

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

31 managers, USD 409m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Avalo Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Deep Track Capital1 fund on PPLI.comUSD 67m1.0%
2Farallon Capital Management56 funds on PPLI.comUSD 46m0.2%
3POINT72 Asset Management17 funds on PPLI.comUSD 44m0.0%
4Avoro Capital Advisors1 fund on PPLI.comUSD 43m0.4%
5Adage Capital Management1 fund on PPLI.comUSD 32m0.0%
6Braidwell12 funds on PPLI.comUSD 30m1.1%
7Logos Global Management1 fund on PPLI.comUSD 21m0.9%
8Ra Capital Management1 fund on PPLI.comUSD 18m0.2%
9Balyasny Asset Management25 funds on PPLI.comUSD 16m0.0%
10Boothbay Fund Management2 funds on PPLI.comUSD 13m0.2%
11Squarepoint Ops7 funds on PPLI.comUSD 11m0.0%
12Baker Bros. Advisors2 funds on PPLI.comUSD 10m0.1%
13Boxer Capital Management1 fund on PPLI.comUSD 6.9m0.5%
14Renaissance Technologies13 funds on PPLI.comUSD 6.6m0.0%
15Citadel Advisors32 funds on PPLI.comUSD 6m0.0%
16Schonfeld Strategic Advisors30 funds on PPLI.comUSD 5.7m0.0%
17Eagle Health Investments1 fund on PPLI.comUSD 4.3m0.7%
18Sphera Funds Management1 fund on PPLI.comUSD 4.3m0.6%
19Perceptive Advisors6 funds on PPLI.comUSD 4.1m0.1%
20Acuta Capital Partners2 funds on PPLI.comUSD 3.4m2.4%
21Walleye Capital8 funds on PPLI.comUSD 3.4m0.0%
22RTW Investments2 funds on PPLI.comUSD 3.2m0.0%
23Ally Bridge Group (Ny)3 funds on PPLI.comUSD 2.8m2.5%
24HighVista Strategies27 funds on PPLI.comUSD 2.3m0.5%
25Two Sigma Investments35 funds on PPLI.comUSD 1.2m0.0%
26Verition Fund Management3 funds on PPLI.comUSD 707,0000.0%
27Verdad Advisers6 funds on PPLI.comUSD 607,0000.6%
28Persistent Asset Partners10 funds on PPLI.comUSD 454,0000.1%
29Exoduspoint Capital Management7 funds on PPLI.comUSD 305,0000.0%
30Jain Global1 fund on PPLI.comUSD 234,0000.0%
31Eversept Partners3 funds on PPLI.comUSD 185,0000.0%
Next: where it matters most
Where it matters most

For Ally Bridge Group (Ny) it is 2.5% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Ally Bridge Group (Ny)USD 2.8m2.5%
2Acuta Capital PartnersUSD 3.4m2.4%
3BraidwellUSD 30m1.1%
4Deep Track CapitalUSD 67m1.0%
5Logos Global ManagementUSD 21m0.9%
6Eagle Health InvestmentsUSD 4.3m0.7%
7Verdad AdvisersUSD 607,0000.6%
8Sphera Funds ManagementUSD 4.3m0.6%
9Boxer Capital ManagementUSD 6.9m0.5%
10HighVista StrategiesUSD 2.3m0.5%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Avalo Therapeutics, Inc.

What is the ticker symbol of Avalo Therapeutics, Inc.?

Avalo Therapeutics, Inc. trades under the symbol AVTX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 05338F306.

Which hedge funds own Avalo Therapeutics, Inc. (Nasdaq: AVTX)?

31 of the 720 hedge fund managers PPLI.com tracks reported Avalo Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Deep Track Capital (USD 67m), Farallon Capital Management (USD 46m), POINT72 Asset Management (USD 44m), Avoro Capital Advisors (USD 43m) and Adage Capital Management (USD 32m).

How many hedge funds hold Avalo Therapeutics, Inc.?

31 managers in our coverage reported it, and between them they run 317 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Avalo Therapeutics, Inc.?

Ally Bridge Group (Ny), where the position was 2.5% of the reported 13F book at 30 June 2026.

Does this show who is short Avalo Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Avalo Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.